Definitive Healthcare Corp. (NASDAQ:DH) finished Friday with a subtraction of -$0.17 to close at $10.99, a downside of -1.52 percent. An average of 514,260 shares of common stock have been traded in the last five days. There was a fall of -$0.77 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 716,045 shares traded, while the 50-day average volume stands at 787,382.
DH stock has decreased by -3.34% in the last month. The company shares reached their 1-month lowest point of $10.70 on 12/29/22. With the stock rallying to its 52-week high on 08/04/22, shares of the company touched a low of $9.53 and a high of $30.11 in 52 weeks. It has reached a new high 3 times so far this year and lost -59.79% or -$16.34 in price. In spite of this, the price is down -63.50% from the 52-week high.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
DH stock investors should be aware that Definitive Healthcare Corp. (DH) stock had its last reported insider trading activity 144 days ago on Nov 07. In this transaction, the insider spent $23,114,000. Director, SEA VII Management, LLC, disposed of 1,100,000 shares at a price of $24.50 on Aug 08. The insider now owns more than $26,950,000 worth of shares. Prior to that, Director Winn David Randall went on to Sale 2,200,000 shares at $24.02 each on Aug 08. An amount of $52,855,000 was transacted.
Definitive Healthcare Corp. (DH) has a trailing price-to-sales (P/S) ratio at 5.70, the price-to-book (PB) ratio at 1.21, and the price-to-cash flow ratio at 30.08.
The quick ratio of Definitive Healthcare Corp. for the three months ended June 29 was 3.30, and the current ratio was 3.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.28 and a total debt to equity ratio of 0.29 for the quarter ending June 29. Its gross profit as reported stood at $125.47 million compared to revenue of $166.15 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Definitive Healthcare Corp.’s return on assets was -1.20%.
For the three-month period that ended June 29, Definitive Healthcare Corp. had $120.8 million in cash and short-term investments compared to $259.06 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$2.69 million in the quarter, while revenues of -$5.15 million were shrunk -196.65%. The analyst consensus anticipated Definitive Healthcare Corp.’s latest quarter earnings to come in at $0.05 per share, but it turned out to be $0.06, a 20.00% surprise. For the quarter, EBITDA amounted to $6.22 million. Shareholders own equity worth $105.08 million.
From a technical analysis perspective, let’s take a brief look at Definitive Healthcare Corp. (DH) price momentum. RSI 9-day as of the close on 30 December was 36.84%, suggesting the stock is Neutral, with historical volatility in this time frame at 28.88%.
As of today, DH’s price is $11.15 -6.55% or -$0.77 from its 5-day moving average. DH is currently trading -8.42% lower than its 20-day SMA and -53.92% lower than its 100-day SMA. However, the stock’s current price level is -23.84% below the SMA50 and -49.28% below the SMA200.
The stochastic %K and %D were 12.68% and 12.01%, respectively, and the average true range (ATR) was 0.66. With the 14-day stochastic at 12.08% and the average true range at 0.71, the RSI (14) stands at 40.18%. The stock has reached -0.34 on the 9-day MACD Oscillator while the 14-day reading was at -0.56.
BofA Securities launched coverage on Definitive Healthcare Corp. (NASDAQ: DH) in its analyst report released on December 09, 2022. The firm assigned the stock a Neutral rating.